KAYLUNRIE

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune dis Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations

Classification kind code

Mark Details

Serial Number

2212720

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 11^th Mar 2025	Search Recorded
Submitted for opposition 20 on 11^th Mar 2025	Examiner's First Report
Submitted for opposition 287 on 6^th Oct 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 29^th Sept 2022	Filed
Submitted for opposition 1 on 29^th Sept 2022	Created
Submitted for opposition 31 on 29^th Sept 2022	Formalized